63 Million Shares traded since announcement, page-32

First 32 Last

Share
Profile

Follow
Lopez

2,965 Posts.

3

05/04/18

19:40

Post #: 32253283
Share

Originally posted by Shellbell ↑

If shareholders vote against Merck's offer and the NO vote (miraculously) gets over the line, Merck may decide to no longer fund the combo trials. BMS never commited to paying for the trials involving their drugs... nuh, they let VLA pay for it... so might Merck this time around given a snubbing of their offer.

So, if VLA was put back on the market, we may as well kiss goodbye at least half the premium Merck are willing to pay at this point in time, plus the $50m in the bank will diminish pretty quick with VLA having to prove its worth again.

The company's market capitalisation (and the value of our shares) will be at the mercy of the stock market's "wheel of fortune" once again. Stuff that... not to mention that we are sitting more and more precariously close to the 10th year average for a stock market crash. In fact, we are sitting smack on top of the precipice. Don't mean to sound like an alarmist, but "Hello"!!!

Expand

Hi,
In the case of Yervoy it’s takes the drug with sales of a $ Billion to maybe $ 5 billion per annum.
I also follow Biotech deals in the States and I must admit I don’t see Merck and BMS bidding too much against each other. Still Cavatak is worth big money to other companies wanting positive combination.
Aloha

VLA Price at posting: $1.68 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OEC

Orbital Corporation completes AATI flight trials and additional orders received

RAU

Resouro Strategic lodges mining concession application for Novo Mundo gold project

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

Dale Gillham: Could this be the most misleading reporting season in years?

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

KLV

Klevo Rewards advances stablecoin strategy with credit licence acquisition

HotCopper Highlights, Week 30: American T&A acquisition, PolyNovo pressure, & Racura trials

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

UM1

Unity Metals hits wide zone of gold at O'Phlay in Cambodia

First 32 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

63 Million Shares traded since announcement, page-32

Top Stories

Orbital Corporation completes AATI flight trials and additional orders received

Resouro Strategic lodges mining concession application for Novo Mundo gold project

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

Dale Gillham: Could this be the most misleading reporting season in years?

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

Klevo Rewards advances stablecoin strategy with credit licence acquisition

HotCopper Highlights, Week 30: American T&A acquisition, PolyNovo pressure, & Racura trials

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Unity Metals hits wide zone of gold at O'Phlay in Cambodia

Featured News